SEMABIZ, Inc. | ChosaReport.com

日本と海外の市場調査レポート＆サービスを取り扱っております。

組織工学と組織再生の技術と世界市場

Tissue Engineering and Regeneration: Technologies and Global Markets

商品番号：SMB-83063
出版社BCC Research
出版年月2025年7月
ページ数131
価格タイプシングルユーザライセンス
価格USD 4,650
種別英文調査報告書

Report Highlights

The global market for tissue engineering and regeneration was valued at $4.8 billion in 2024 and is estimated to increase from $5.4 billion in 2025 to reach $9.8 billion by 2030, at a compound annual growth rate (CAGR) of 12.8% from 2025 through 2030.

Report Includes

  • 47 data tables and 64 additional tables
  • Analyses of the trends in global markets for tissue engineering and regeneration technologies, with historic revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
  • Estimates of the market’s size and revenue prospects, accompanied by a market share analysis by product type, material, application and region
  • Facts and figures pertaining to market dynamics, technological advances, regulations and the impact of macroeconomic factors
  • Insights derived from Porter’s Five Forces model, as well as global supply chain analysis
  • Patent analysis, featuring key granted and published patents
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
  • Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
  • Company profiles of major players within the industry, including Organogenesis Inc., Integra LifeSciences, Smith+Nephew, MiMedx Group Inc., and Johnson & Johnson Services Inc.

Report Scope

The report provides an overview of the global tissue engineering and regeneration market and analyzes market trends. It includes global revenue ($ million) using 2024 as the base year, estimated data for 2025, and projected data for 2026 through 2030.

The market is segmented into product type, material, and application. By product, the market is categorized into scaffolds and tissue grafts. By material, the market is segmented into biologically derived materials and synthetic materials. Based on application, the market is segmented into orthopedic and musculoskeletal disorders, dermatology and wound care, dental disorders, cardiovascular diseases, and others. Geographical regions covered in this study are North America (the U.S., Canada, and Mexico), Europe (Germany, the U.K., Italy, France, and the Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), the Middle East and Africa (MEA), and South America, focusing on all the major countries in these regions.

The report focuses on the significant driving trends and challenges that affect the market and vendor landscape. It analyzes environmental, social and corporate governance (ESG) developments and discusses emerging technologies related to the market.

The report concludes by analyzing the competitive landscape and providing the ranking/share of key global tissue engineering and regeneration companies. It also contains a dedicated section of company profiles that covers details such as overview, key financials, product portfolio and recent developments in major companies.

Report Synopsis

Report MetricsDetails
Base year considered2024
Forecast period considered2025-2030
Base year market size$4.8 billion
Market size forecast$9.8 billion
Growth rateCAGR of 12.8% for the forecast period of 2025-2030
Units considered$ Millions
Segments coveredProduct Type, Material, Equipment, Region
Regions coveredNorth America, Europe, Asia-Pacific, South America, Middle East and Africa
Countries coveredU.S., Canada, Mexico, U.K., France, Italy, Germany, Spain, Poland, the Czech Republic, Hungary, Austria, Slovakia, Slovenia, China, India, Japan, Australia, South Korea, Thailand, Singapore, Vietnam
Key Market Drivers
  • Rising Demand for Regenerative Medicine
  • Growing Research and Approvals in Tissue Engineering
  • Increasing Venture Capital Funding
Companies studied
ABBVIE INC.ALICORN MEDICAL PVT. LTD.
BAXTERB. BRAUN SE
BDBIOTISSUE
INTEGRA LIFESCIENCESJOHNSON & JOHNSON SERVICES INC.
MEDTRONICMIMEDX GROUP INC.
ORGANOGENESIS INC.SMITH+NEPHEW
STRYKERTECNOSS
ZIMMER BIOMET

Executive Summary

Summary:

The global market for tissue engineering and regeneration was valued at $4.8 billion in 2024 and is estimated to increase from $5.4 billion in 2025 to reach $9.8 billion by 2030, at a compound annual growth rate (CAGR) of 12.8% from 2025 through 2030.

Tissue engineering is a multidisciplinary field focused on producing biological substitutes to restore or enhance tissue and organ function. It integrates engineering, medicine and physiology, using components such as stem cells, scaffolds and bioactive molecules. Stem cells differentiate into specific cell types, scaffold supports their growth and bioactive molecules guide tissue formation. Graft-based therapies, such as autologous allografts, xenografts and synthetic grafts, are commonly used in clinical applications, including skin, bone and soft tissue repair. Advances in biomaterials and scaffold design have improved graft results, allowing better imitation of natural tissue structures and improved regenerative outcomes through integration with growth factors and cellular therapies.

Current Market Scenario

The tissue engineering market is experiencing strong growth, primarily driven by the rising demand for regenerative medicine to treat chronic and degenerative diseases. Increasing research activities and rising product approvals are accelerating innovation and clinical adoption. Technological advances such as 3D bioprinting, smart biomaterials and AI integration augment treatment precision and expand application scope. However, the market faces challenges, including high treatment costs and complex regulatory pathways that can delay commercialization. Additionally, emerging economies offer significant growth potential due to expanding healthcare infrastructure, supportive government policies and rising healthcare awareness.

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Porter’s Five Forces Analysis in the Tissue Engineering and Regeneration Market
Potential for New Entrants (Moderate to High)
Bargaining Power of Suppliers (Moderate to High)
Bargaining Power of Buyers (High)
Threat of Substitutes (Low to Moderate)
Competition in the Industry (High)
Macroeconomic Factor Analysis
Aging Population
Regulatory Environment
Government Policy and Collaboration
The U.S. Tariff Scenario
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Rising Demand for Regenerative Medicine
Growing Research and Approvals in Tissue Engineering
Increasing Venture Capital Funding
Market Restraints
High Cost Associated with Treatment
Complex Regulatory Pathway
Market Opportunities
Technological Advances
Emerging Economies
Chapter 4 Regulatory Landscape
The U.S.
Europe
Asia-Pacific
Chapter 5 Impact of AI Adoption on the Tissue Engineering and Regeneration Market
Overview
Case Studies
Problem
Solution
Outcome
AI Adoption: Trends
Adoption Trends in North America
Adoption Trends in Europe
Adoption Trends in the Rest of the World
AI Disruption Trends
Impact of AI on Various Stages of the Value Chain
Market Spending and Investment Scenario
VC Investment in AI
Chapter 6 Emerging Technologies and Developments
Emerging Technologies
3D Bioprinting
Organ-on-a-Chip
Smart Biomaterial
Artificial Intelligence
Clinical Trials Analysis
Key Takeaways
Clinical Trials Analysis, by Type of Study
Clinical Trials Analysis, by Status
Clinical Trials Analysis, by Phase
Patent Analysis
Key Takeaways
Patents, by Year
Patents by Top Applicant
Patents by Top Owner
Patents by Jurisdiction
Chapter 7 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis by Product Type
Key Takeaways
Scaffolds
Biological Scaffolds
Synthetic Scaffolds
Grafts
Allogenic
Autogenic
Synthetic
Xenogeneic
Market Analysis by Material
Key Takeaways
Biologically Derived Material
Synthetic Material
Market Analysis by Application
Key Takeaways
Orthopedics and Musculoskeletal Disorders
Dermatology and Wound Care
Dental Disorders
Cardiovascular Diseases
Others
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
Middle East and Africa (MEA)
South America
Chapter 8 Competitive Intelligence
Key Takeaways
Competitive Landscape
Global Market Shares of Leading Companies
Key Developments and Strategies
Chapter 9 Sustainability in Tissue Engineering and Regeneration: An ESG Perspective
Introduction to ESG
Sustainability in Tissue Engineering and Regeneration: An ESG Perspective
Key ESG Issues
Tissue Engineering and Regeneration ESG Performance Analysis
Concluding Remarks from BCC
Chapter 10 Appendix
Methodology
Sources
Abbreviations
Company Profiles
ABBVIE INC.
ALICORN MEDICAL PVT. LTD.
BAXTER
B. BRAUN SE
BD
BIOTISSUE
INTEGRA LIFESCIENCES
JOHNSON & JOHNSON SERVICES INC.
MEDTRONIC
MIMEDX GROUP INC.
ORGANOGENESIS INC.
SMITH+NEPHEW
STRYKER
TECNOSS
ZIMMER BIOMET
A Few Emerging Start-ups/Market Disruptors

List of Tables

List of Tables
Summary Table : Global Market for Tissue Engineering and Regeneration, by Region, Through 2030
Table 1 : Porter’s Five Forces Analysis: Overview
Table 2 : Tissue Engineering and Regeneration: Venture Capital Funding, 2024
Table 3 : Tissue Engineering & Regeneration: Pricing
Table 4 : Tissue Engineering and Regeneration: Regulatory Overview, 2025
Table 5 : Asia-Pacific: Regulatory Landscape, 2024
Table 6 : Clinical Trials in Tissue Engineering, by Type of Study, June 2025
Table 7 : Clinical Trials in Tissue Engineering, by Status, June 2025
Table 8 : Clinical Trials in Tissue Engineering, by Phase, June 2025
Table 9 : Patents, by Top Applicant, 2021–2024
Table 10 : Patents, by Top Owner, 2021–2024
Table 11 : Patents, by Jurisdiction, 2021–2024
Table 12 : Global Market for Tissue Engineering and Regeneration, by Product Type, Through 2030
Table 13 : Comparison of Extracellular Matrix Functions and Scaffold Analogs in Tissue Engineering
Table 14 : Global Market for Scaffolds in Tissue Engineering and Regeneration, by Type, Through 2030
Table 15 : Biological Scaffold Materials: Advantages and Disadvantages
Table 16 : Synthetic Scaffold Materials: Advantages and Disadvantages
Table 17 : Global Market for Grafts in Tissue Engineering and Regeneration, by Source, Through 2030
Table 18 : List of Bioengineered Autogenic Grafts
Table 19 : Global Market for Tissue Engineering and Regeneration, by Material, Through 2030
Table 20 : Tissue Engineering and Regeneration: Biomaterial
Table 21 : Global Market for Tissue Engineering and Regeneration, by Application, Through 2030
Table 22 : Orthopedics and Musculoskeletal Disorders: Tissue Engineering and Regeneration Product
Table 23 : Dermatology and Wound Care: Tissue Engineering and Regeneration Products
Table 24 : Global Market for Tissue Engineering and Regeneration, by Region, Through 2030
Table 25 : North American Market for Tissue Engineering and Regeneration, by Country, Through 2030
Table 26 : North American Market for Tissue Engineering and Regeneration, by Product Type, Through 2030
Table 27 : North American Market for Scaffolds in Tissue Engineering and Regeneration, by Type, Through 2030
Table 28 : North American Market for Grafts in Tissue Engineering and Regeneration, by Source, Through 2030
Table 29 : North American Market for Tissue Engineering and Regeneration, by Material, Through 2030
Table 30 : North American Market for Tissue Engineering and Regeneration, by Application, Through 2030
Table 31 : European Market for Tissue Engineering and Regeneration, by Country, Through 2030
Table 32 : European Market for Tissue Engineering and Regeneration, by Product Type, Through 2030
Table 33 : European Market for Scaffolds in Tissue Engineering and Regeneration, by Type, Through 2030
Table 34 : European Market for Grafts in Tissue Engineering and Regeneration, by Source, Through 2030
Table 35 : European Market for Tissue Engineering and Regeneration, by Material, Through 2030
Table 36 : European Market for Tissue Engineering and Regeneration, by Application, Through 2030
Table 37 : Asia-Pacific Market for Tissue Engineering and Regeneration, by Country, Through 2030
Table 38 : Asia-Pacific Market for Tissue Engineering and Regeneration, by Product Type, Through 2030
Table 39 : Asia-Pacific Market for Scaffolds in Tissue Engineering and Regeneration, by Type, Through 2030
Table 40 : Asia-Pacific Market for Graft in Tissue Engineering and Regeneration, by Source, Through 2030
Table 41 : Asia-Pacific Market for Tissue Engineering and Regeneration, by Material, Through 2030
Table 42 : Asia-Pacific Market for Tissue Engineering and Regeneration, by Application, Through 2030
Table 43 : MEA Market for Tissue Engineering and Regeneration, by Product Type, Through 2030
Table 44 : MEA Market for Scaffolds in Tissue Engineering and Regeneration, by Type, Through 2030
Table 45 : MEA Market for Graft in Tissue Engineering and Regeneration, by Source, Through 2030
Table 46 : MEA Market for Tissue Engineering and Regeneration, by Material, Through 2030
Table 47 : MEA Market for Tissue Engineering and Regeneration, by Application, Through 2030
Table 48 : South American Market for Tissue Engineering and Regeneration, by Product Type, Through 2030
Table 49 : South American Market for Scaffolds in Tissue Engineering and Regeneration, by Type, Through 2030
Table 50 : South American Market for Graft in Tissue Engineering and Regeneration, by Source, Through 2030
Table 51 : South American Market for Tissue Engineering and Regeneration, by Material, Through 2030
Table 52 : South American Market for Tissue Engineering and Regeneration, by Application, Through 2030
Table 53 : Top 5 Leading Manufacturers of Tissue Engineering and Regeneration Market, 2024
Table 54 : Tissue Engineering and Regeneration: Recent Strategic Developments, 2022–2025
Table 55 : ESG Rankings in Tissue Engineering and Regeneration Companies, 2025*
Table 56 : ESG: Environmental Overview
Table 57 : ESG: Social Overview
Table 58 : ESG: Governance Overview
Table 59 : Report Information Sources
Table 60 : Abbreviations Used in the Global Tissue Engineering and Regeneration Market Report
Table 61 : AbbVie Inc.: Company Snapshot
Table 62 : AbbVie Inc.: Financial Performance, FY 2023 and 2024
Table 63 : AbbVie Inc.: Product Portfolio
Table 64 : AbbVie Inc.: News/Key Developments, 2023
Table 65 : Alicorn Medical Pvt. Ltd.: Company Snapshot
Table 66 : Alicorn Medical Pvt. Ltd.: Product Portfolio
Table 67 : Alicorn Medical Pvt. Ltd.: News/Key Developments, 2025
Table 68 : Baxter: Company Snapshot
Table 69 : Baxter: Financial Performance, FY 2023 and 2024
Table 70 : Baxter: Product Portfolio
Table 71 : B. Braun SE: Company Snapshot
Table 72 : B. Braun SE: Financial Performance, FY 2023 and 2024
Table 73 : B. Braun SE: Product Portfolio
Table 74 : BD: Company Snapshot
Table 75 : BD: Financial Performance, FY 2023 and 2024
Table 76 : BD: Product Portfolio
Table 77 : BD: News/Key Developments, 2025
Table 78 : BioTissue: Company Snapshot
Table 79 : BioTissue: Product Portfolio
Table 80 : BioTissue: News/Key Developments, 2022 and 2024
Table 81 : Integra LifeSciences: Company Snapshot
Table 82 : Integra LifeSciences: Financial Performance, FY 2023 and 2024
Table 83 : Integra LifeSciences: Product Portfolio
Table 84 : Integra LifeSciences: News/Key Developments, 2022
Table 85 : Johnson & Johnson Services Inc.: Company Snapshot
Table 86 : Johnson & Johnson Services Inc.: Financial Performance, FY 2023 and 2024
Table 87 : Johnson & Johnson Services Inc.: Product Portfolio
Table 88 : Medtronic: Company Snapshot
Table 89 : Medtronic: Financial Performance, FY 2023 and 2024
Table 90 : Medtronic: Product Portfolio
Table 91 : MIMEDX Group Inc.: Company Snapshot
Table 92 : MIMEDX Group Inc.: Financial Performance, FY 2023 and 2024
Table 93 : MIMEDX Group Inc.: Product Portfolio
Table 94 : MIMEDX Group Inc.: News/Key Developments, 2022-2024
Table 95 : Organogenesis Inc.: Company Snapshot
Table 96 : Organogenesis Inc.: Financial Performance, FY 2023 and 2024
Table 97 : Organogenesis Inc.: Product Portfolio
Table 98 : Smith+Nephew: Company Snapshot
Table 99 : Smith+Nephew: Financial Performance, FY 2023 and 2024
Table 100 : Smith+Nephew: Product Portfolio
Table 101 : Smith+Nephew: News/Key Developments, 2023 and 2024
Table 102 : Stryker: Company Snapshot
Table 103 : Stryker: Financial Performance, FY 2023 and 2024
Table 104 : Stryker: Product Portfolio
Table 105 : Tecnoss: Company Snapshot
Table 106 : Tecnoss: Product Portfolio
Table 107 : Zimmer Biomet: Company Snapshot
Table 108 : Zimmer Biomet: Financial Performance, FY 2023 and 2024
Table 109 : Zimmer Biomet: Product Portfolio
Table 110 : List of a Few Emerging Start-ups/ Market Disruptors

List of Figures

List of Figures
Summary Figure : Global Market Shares of Tissue Engineering and Regeneration, by Region, 2024
Figure 1 : Tissue Engineering: Triad
Figure 2 : Porter’s Five Forces Analysis of the Tissue Engineering and Regeneration Market
Figure 3 : Market Dynamics of Tissue Engineering and Regeneration
Figure 4 : Number of Publications, by Year, 2021-2024
Figure 5 : AI in Tissue Engineering
Figure 6 : AI: Global Leaders, Ranking, 2025
Figure 7 : Impact of AI on Key Industry Verticals
Figure 8 : Impact of AI on Value Chain
Figure 9 : Emerging Trends/Technologies in the Tissue Engineering and Regeneration Market
Figure 10 : Patents Granted, by Year, 2021-2024
Figure 11 : Global Market Shares of Tissue Engineering and Regeneration, by Product Type, 2024
Figure 12 : Global Market Shares of Scaffolds in Tissue Engineering and Regeneration, by Type, 2024
Figure 13 : Global Market Shares of Grafts in Tissue Engineering and Regeneration, by Source, 2024
Figure 14 : Global Market Shares of Tissue Engineering and Regeneration, by Material, 2024
Figure 15 : Global Market Shares of Tissue Engineering and Regeneration, by Application, 2024
Figure 16 : Global Market Shares of Tissue Engineering and Regeneration, by Region, 2024
Figure 17 : North American Market Shares of Tissue Engineering and Regeneration, by Country, 2024
Figure 18 : European Market Shares of Tissue Engineering and Regeneration, by Country, 2024
Figure 19 : Asia-Pacific Market Shares of Tissue Engineering and Regeneration, by Country, 2024
Figure 20 : Company Share Analysis of Tissue Engineering and Regeneration Market, 2024
Figure 21 : ESG Pillars
Figure 22 : Advantages of ESG for Companies
Figure 23 : AbbVie Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 24 : AbbVie Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 25 : Baxter: Revenue Shares, by Business Unit, FY 2024
Figure 26 : Baxter: Revenue Shares, by Country/Region, FY 2024
Figure 27 : B. Braun SE: Revenue Shares, by Business Unit, FY 2024
Figure 28 : B. Braun SE: Revenue Shares, by Country/Region, FY 2024
Figure 29 : BD: Revenue Shares, by Business Unit, FY 2024
Figure 30 : BD: Revenue Shares, by Country/Region, FY 2024
Figure 31 : Integra LifeSciences: Revenue Shares, by Business Segment, FY 2024
Figure 32 : Integra LifeSciences: Revenue Shares, by Country/Region, FY 2024
Figure 33 : Johnson & Johnson Services Inc.: Revenue Shares, by Business Segment, FY 2024
Figure 34 : Johnson & Johnson Services Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 35 : Medtronic: Revenue Shares, by Business Segment, FY 2024
Figure 36 : Medtronic: Revenue Shares, by Country/Region, FY 2024
Figure 37 : MIMEDX Group Inc.: Revenue Shares, by Business Segment, FY 2024
Figure 38 : Organogenesis Inc.: Revenue Shares, by Business Segment, FY 2024
Figure 39 : Smith+Nephew: Revenue Shares, by Business Segment, FY 2024
Figure 40 : Smith+Nephew: Revenue Shares, by Country/Region, FY 2024
Figure 41 : Stryker: Revenue Shares, by Business Segment, FY 2024
Figure 42 : Stryker: Revenue Shares, by Country/Region, FY 2024
Figure 43 : Zimmer Biomet: Revenue Shares, by Business Segment, FY 2024
Figure 44 : Zimmer Biomet: Revenue Shares, by Country/Region, FY 2024

医療・医薬の最新記事8件